期刊文献+

ERG11 mutations associated with azole resistance in Candida albicans isolates from vulvovaginal candidosis patients

ERG11 mutations associated with azole resistance in Candida albicans isolates from vulvovaginal candidosis patients
下载PDF
导出
摘要 Objective: To investigate the azole susceptibility of Candida albicans(C.albicans)from vulvovaginal candidosis patients and to analyze the relationship between ERG11 gene mutations in these isolates and azole resistance.Methods: Three hundred and two clinical isolates of Candida species were collected.Azole susceptibility was tested in vitro in microdilution studies. The ERG11 genes of 17 isolates of C. albicans(2 susceptibles, 5 dose-dependent resistants and 10 resistants) were amplified and sequenced.Results: Of the 302 isolates collected, 70.2% were C. albicans, of which 8.5%, 3.8% and4.2% were resistant to fluconazole, itraconazole and voriconazole, respectively. In total,27 missense mutations were detected in ERG11 genes from resistant/susceptible dosedependent isolates. Among them, Y132 H, A114 S, and Y257 H substitutions were most prevalent and were known to cause fluconazole resistance. G464 S and F72 S also have been proved to cause fluconazole resistance. Two novel substitutions(T285A, S457P) in hotspot regions were identified.Conclusions: Twenty seven mutations in the ERG11 gene were identified in azoleresistant C. albicans isolates, which indicated a possible relation with the increase in resistance to azole drugs and the recurrence of vulvovaginal candidosis. The relationship of two novel substitutions(T285A, S457P) with fluconazole resistance needs to be further verified by site-directed mutagenesis. Objective: To investigate the azole susceptibility of Candida albicans(C.albicans)from vulvovaginal candidosis patients and to analyze the relationship between ERG11 gene mutations in these isolates and azole resistance.Methods: Three hundred and two clinical isolates of Candida species were collected.Azole susceptibility was tested in vitro in microdilution studies. The ERG11 genes of 17 isolates of C. albicans(2 susceptibles, 5 dose-dependent resistants and 10 resistants) were amplified and sequenced.Results: Of the 302 isolates collected, 70.2% were C. albicans, of which 8.5%, 3.8% and4.2% were resistant to fluconazole, itraconazole and voriconazole, respectively. In total,27 missense mutations were detected in ERG11 genes from resistant/susceptible dosedependent isolates. Among them, Y132 H, A114 S, and Y257 H substitutions were most prevalent and were known to cause fluconazole resistance. G464 S and F72 S also have been proved to cause fluconazole resistance. Two novel substitutions(T285A, S457P) in hotspot regions were identified.Conclusions: Twenty seven mutations in the ERG11 gene were identified in azoleresistant C. albicans isolates, which indicated a possible relation with the increase in resistance to azole drugs and the recurrence of vulvovaginal candidosis. The relationship of two novel substitutions(T285A, S457P) with fluconazole resistance needs to be further verified by site-directed mutagenesis.
出处 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第11期909-914,共6页 亚太热带生物医学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China(No.31072125 and 31272549) by a National Science and Technology Project (China) grant (2008ZX-10004-011)
关键词 CANDIDA ALBICANS AZOLES resistance ERG11 gene Muta Candida albicans Azoles resistance ERG11 gene Muta
  • 相关文献

参考文献18

  • 1Umme Hani,Hosakote G. Shivakumar,Rudra Vaghela,Riyaz Ali M. Osmani,Atul Shrivastava.Candidiasis: A Fungal Infection- Current Challenges and Progress in Prevention and Treatment[J]. Infectious Disorders - Drug Targets . 2015 (1)
  • 2Jie‐Yu Zhang,Jin‐Hui Liu,Fa‐Di Liu,Yan‐Hua Xia,Jing Wang,Xi Liu,Zhi‐Qin Zhang,Na Zhu,Yan‐Yan,Ying Ying,Xiao‐Tian Huang.Vulvovaginal candidiasis : species distribution, fluconazole resistance and drug efflux pump gene overexpression[J]. Mycoses . 2014 (10)
  • 3X.P. Liu,S.R. Fan,Y.T. Peng,H.P. Zhang.Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012[J]. Journal de Mycologie Médicale . 2014
  • 4A. Kalkanci,A. B. Güzel,I. I. K. Jabban,M. Aydin,M. Ilkit,S. Ku?timur.Candida vaginitis in non-pregnant patients: A study of antifungal susceptibility testing and virulence factors[J]. Journal of Obstetrics & Gynaecology . 2013 (4)
  • 5Jie Zhao,Yonghao Xu,Chunyang Li.Association of T916C (Y257H) mutation in Candida albicans ERG11 with fluconazole resistance[J]. Mycoses . 2012 (3)
  • 6The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs[J]. Journal de Mycologie Médicale . 2012 (2)
  • 7Jana Cernicka,Julius Subik.Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis[J]. International Journal of Antimicrobial Agents . 2006 (5)
  • 8Yasuki Kamai,Kazunori Maebashi,Michinari Kudoh,Koichi Makimura,Wataru Naka,Katsuhisa Uchida,Hideyo Yamaguchi.Characterization of Mechanisms of Fluconazole Resistance in a Candida albicans Isolate from a Japanese Patient with Chronic Mucocutaneous Candidiasis[J]. Microbiology and Immunology . 2004 (12)
  • 9Lai M H,Kirsch D R.Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. Nucleic Acids Research . 1989
  • 10Heilmann Clemens J,Schneider Sabrina,Barker Katherine S,Rogers P David,Morschh?user Joachim.An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Antimicrobial Agents and Chemotherapy . 2009

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部